HOD HASHARON, Israel, March 15, 2024 /PRNewswire/ -- FarmSee, a pioneer in camera-based Artificial Intelligence ("AI") solutions for swine monitoring and production optimization, is excited to announce a strategic collaboration with MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK). MSD Animal Health, a biopharmaceuticals and technology solutions company, has participated in FarmSee's A round and has entered into a long-term agreement to integrate FarmSee's AI- based weighing technology into its global offerings for swine producers. FarmSee also has partnered with Munters (STO:MTRS) in their A round funding.
FarmSee, a privately held company headquartered in Israel, harnesses the power of computer vision and AI to provide the swine production industry with actionable insights, derived from critical information about every individual animal. FarmSee's Initial focus is on continuous individual weight monitoring, which is critical for tracking the animals' growth pattern. FarmSee plans to expand its technology to encompass additional insights into behavior, health, and nutrition.
"We are thrilled to collaborate with MSD Animal Health and view this investment as an exciting opportunity to work with a leading company to further develop our innovative technology," said Nimrod Madar, CEO of FarmSee. "This collaboration not only validates the value of our technology but also opens new opportunities for growth and expansion for FarmSee. It reaffirms our commitment to empowering producers with data-driven optimization while ensuring animal well-being and welfare."
"MSD Animal Health has supported FarmSee's technology from the early stages of their journey. We look forward to the growth and development of FarmSee's swine-monitoring technology, which will integrate into our suite of identification, monitoring and traceability animal health solutions. We are committed to positively impacting the health and well-being of animals and driving positive change for pork producers worldwide," said Stephen Murray, associate vice president, MSD Animal Health Ventures.
About FarmSee
FarmSee advocates for the adoption of data-driven practices as the optimal path towards industry optimization. The company firmly believes in harnessing the power of technology to unlock the full potential of our industry and achieve optimal production outcomes. By utilizing state-of-the-art computer vision and AI technologies to collect and analyze precise data on swine, FarmSee empowers producers to make informed decisions that drive efficiency, productivity, and profitability, while prioritizing animal welfare, biosecurity and sustainability.
For media inquiries, please contact:
Nimrod Madar
CEO
This email address is being protected from spambots. You need JavaScript enabled to view it.
FarmSee
24 HaNagar St. Hod HaSharon, Israel
www.farmsee.com
Last Trade: | US$99.85 |
Daily Change: | -0.21 -0.21 |
Daily Volume: | 1,152,522 |
Market Cap: | US$252.620B |
December 18, 2024 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB